Wednesday, 2 June 2021

Serum Institute Seeks Indemnity, Says "Same Rules For All": Sources

After Pfizer and Moderna, Covishield-maker Serum Institute of India (SII) has asked for indemnity from liability, according to sources.

from NDTV News - Special https://ift.tt/3pjasEe
via IFTTT
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)